This topic contains a solution. Click here to go to the answer

Author Question: In the long run, even if new fringe firms enter the oligopoly market, the dominant firm's profit ... (Read 102 times)

mckennatimberlake

  • Hero Member
  • *****
  • Posts: 559
In the long run, even if new fringe firms enter the oligopoly market, the dominant firm's profit will remain unaltered.
  Indicate whether the statement is true or false

Question 2

Economies of scale, control over a scarce input, and patents are all examples of barriers to entry.
 a. True
  b. False
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

meltdown117

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

F

Answer to Question 2

True




mckennatimberlake

  • Member
  • Posts: 559
Reply 2 on: Jun 30, 2018
Wow, this really help


Liamb2179

  • Member
  • Posts: 365
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library